Mr Stemple, who has served on the board for three years, succeeds AstraZeneca's Liz Chatwin who recently left the board following her promotion to a senior US-based role.
Chris Stemple elevated to Medicines Australia deputy chair
February 28, 2022 Latest NewsBioPharmaBioPharmaDispatch ExecutiveLatest Video
New Stories
-
President's nominee denies calling for seizure of pharmaceutical patents
January 30, 2025 - - Latest News -
GPs call on NSW Government to fund free Meningococcal B vaccine
January 30, 2025 - - Latest News -
New Zealand's Pharmac reconsiders proposed move to single oestradiol patch brand
January 30, 2025 - - Latest News -
QBiotics strengthens medical leadership with two senior appointments
January 28, 2025 - - Australian Biotech -
Chemist Warehouse reports strong sales and earnings growth with merger to progress
January 28, 2025 - - Latest News -
Trapped arguing for changes that won't make a meaningful difference
January 28, 2025 - - Latest News -
Medicines Australia wants progress on 'immediate impact' recommendations
January 28, 2025 - - Latest News